Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, Chief Executive ...
SYNGAP1 encephalopathy is a rare genetic disorder for which there is no treatment. It causes epilepsy, intellectual ...
On April 10, 2026, the U.S. Department of Justice (DOJ) announced that International Business Machines Corporation (IBM) ...
In a first-of-its-kind settlement, IBM agreed to pay the feds over allegations it relied on “discriminatory employment ...
It’s the first instance of an employer settling a case that the government brought as part of an initiative to investigate ...
On Friday, April 10, 2026, the Department of Justice (“DOJ”) announced a $17 million False Claims Act (“FCA”) settlement with International Business Machines (“IBM”), based on the company’s alleged ...
IBM has agreed to pay $17 million to settle a US government probe over the firm’s diversity, equity and inclusion (DEI) practices, which President Donald J. Trump’s administration has cracked down on ...
LONDON, April 3 (Reuters) - Some investors think private credit is a tempest in a teapot. Others think it is about to spark a new financial crisis. Depending on the time horizon, both sets of views ...
The Trump administration is poised to broaden access to risky investments that are showing signs of strain. President Trump’s executive order last year called for the inclusion of “alternative assets” ...
Private credit's cracks open door for Wall Street banks' comeback: 'The tug of war is just starting'
Banks see more opportunities to regain share as private credit strains emerge and regulation eases. Private credit faces rising defaults, liquidity pressures and fallout from aggressive lending.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results